Ir al contenido

Moderna, Merck cancer vaccine shows promise in late-stage trial; Moderna stock soars 90%

19 de agosto de 2026 por
Moderna, Merck cancer vaccine shows promise in late-stage trial; Moderna stock soars 90%
OdooBot
The combination regimen significantly extended the time patients lived without their melanoma returning, compared with Keytruda alone.

Fuente original: 

en News
Sacked Ukrainian defence minister calls for presidential election
Portal Veterinario